FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2935291092> ?p ?o ?g. }

• W2935291092 endingPage "e0214884" @default.
• W2935291092 startingPage "e0214884" @default.
• W2935291092 abstract "Panniculitis and vitiligo-like lesions have been recently identified as rare cutaneous side effects of the combination of BRAF and MEK inhibitors, a standard of care in metastatic and locally advanced BRAF V600 mutated melanoma. An immune-mediated mechanism has been advocated in the pathogenesis of these skin lesions. Herein we retrospectively reviewed our institutional experience with the aim to explore the association between the occurrence of panniculitis and vitiligo-like lesions during combination therapy with dabrafenib (D) and trametinib (T) and outcome of advanced melanoma patients. Among 52 consecutive BRAF V600 mutated melanoma patients submitted to DT in our center, 12 (23%) developed immune related skin lesions (IRSLs): 8 panniculitis and 4 vitiligo. Patients with IRSLs diagnosis obtained a better disease response (83% versus 25%) (p = 0.001) than their counterpart and had a longer progression free survival and overall survival. The association of IRSLs and lower risk of disease progression (HR 0.19; CI 95% 0.04-0.90; p = 0.043) was confirmed after adjusting for major prognostic factors in multivariate analysis. IRSLs might represent an easy predictive surrogate marker for treatment response and favourable outcome in melanoma patients submitted to DT combination therapy." @default.
• W2935291092 created "2019-04-11" @default.
• W2935291092 creator A5002769621 @default.
• W2935291092 creator A5020684039 @default.
• W2935291092 creator A5033619203 @default.
• W2935291092 creator A5037851724 @default.
• W2935291092 creator A5040570721 @default.
• W2935291092 creator A5041843488 @default.
• W2935291092 creator A5046524342 @default.
• W2935291092 creator A5050426287 @default.
• W2935291092 creator A5053217678 @default.
• W2935291092 creator A5064297623 @default.
• W2935291092 creator A5090273990 @default.
• W2935291092 date "2019-04-02" @default.
• W2935291092 modified "2023-10-16" @default.
• W2935291092 title "Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy" @default.
• W2935291092 cites W2073713419 @default.
• W2935291092 cites W2114903025 @default.
• W2935291092 cites W2150714188 @default.
• W2935291092 cites W2254594392 @default.
• W2935291092 cites W2295493883 @default.
• W2935291092 cites W2400822340 @default.
• W2935291092 cites W2412210967 @default.
• W2935291092 cites W2519981779 @default.
• W2935291092 cites W2551317550 @default.
• W2935291092 cites W2594575075 @default.
• W2935291092 cites W2611270905 @default.
• W2935291092 cites W2631627985 @default.
• W2935291092 cites W2761314488 @default.
• W2935291092 cites W2808218761 @default.
• W2935291092 cites W2885140428 @default.
• W2935291092 cites W2885790309 @default.
• W2935291092 doi "https://doi.org/10.1371/journal.pone.0214884" @default.
• W2935291092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6445428" @default.
• W2935291092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30939167" @default.
• W2935291092 hasPublicationYear "2019" @default.
• W2935291092 type Work @default.
• W2935291092 sameAs 2935291092 @default.
• W2935291092 citedByCount "12" @default.
• W2935291092 countsByYear W29352910922019 @default.
• W2935291092 countsByYear W29352910922020 @default.
• W2935291092 countsByYear W29352910922021 @default.
• W2935291092 countsByYear W29352910922022 @default.
• W2935291092 countsByYear W29352910922023 @default.
• W2935291092 crossrefType "journal-article" @default.
• W2935291092 hasAuthorship W2935291092A5002769621 @default.
• W2935291092 hasAuthorship W2935291092A5020684039 @default.
• W2935291092 hasAuthorship W2935291092A5033619203 @default.
• W2935291092 hasAuthorship W2935291092A5037851724 @default.
• W2935291092 hasAuthorship W2935291092A5040570721 @default.
• W2935291092 hasAuthorship W2935291092A5041843488 @default.
• W2935291092 hasAuthorship W2935291092A5046524342 @default.
• W2935291092 hasAuthorship W2935291092A5050426287 @default.
• W2935291092 hasAuthorship W2935291092A5053217678 @default.
• W2935291092 hasAuthorship W2935291092A5064297623 @default.
• W2935291092 hasAuthorship W2935291092A5090273990 @default.
• W2935291092 hasBestOaLocation W29352910921 @default.
• W2935291092 hasConcept C126322002 @default.
• W2935291092 hasConcept C143998085 @default.
• W2935291092 hasConcept C16005928 @default.
• W2935291092 hasConcept C184235292 @default.
• W2935291092 hasConcept C2776131300 @default.
• W2935291092 hasConcept C2776999253 @default.
• W2935291092 hasConcept C2777658100 @default.
• W2935291092 hasConcept C2778077071 @default.
• W2935291092 hasConcept C2778472372 @default.
• W2935291092 hasConcept C2778830669 @default.
• W2935291092 hasConcept C2779980618 @default.
• W2935291092 hasConcept C2994587330 @default.
• W2935291092 hasConcept C502942594 @default.
• W2935291092 hasConcept C57074206 @default.
• W2935291092 hasConcept C71924100 @default.
• W2935291092 hasConcept C86803240 @default.
• W2935291092 hasConcept C95444343 @default.
• W2935291092 hasConceptScore W2935291092C126322002 @default.
• W2935291092 hasConceptScore W2935291092C143998085 @default.
• W2935291092 hasConceptScore W2935291092C16005928 @default.
• W2935291092 hasConceptScore W2935291092C184235292 @default.
• W2935291092 hasConceptScore W2935291092C2776131300 @default.
• W2935291092 hasConceptScore W2935291092C2776999253 @default.
• W2935291092 hasConceptScore W2935291092C2777658100 @default.
• W2935291092 hasConceptScore W2935291092C2778077071 @default.
• W2935291092 hasConceptScore W2935291092C2778472372 @default.
• W2935291092 hasConceptScore W2935291092C2778830669 @default.
• W2935291092 hasConceptScore W2935291092C2779980618 @default.
• W2935291092 hasConceptScore W2935291092C2994587330 @default.
• W2935291092 hasConceptScore W2935291092C502942594 @default.
• W2935291092 hasConceptScore W2935291092C57074206 @default.
• W2935291092 hasConceptScore W2935291092C71924100 @default.
• W2935291092 hasConceptScore W2935291092C86803240 @default.
• W2935291092 hasConceptScore W2935291092C95444343 @default.
• W2935291092 hasIssue "4" @default.
• W2935291092 hasLocation W29352910921 @default.
• W2935291092 hasLocation W29352910922 @default.
• W2935291092 hasLocation W29352910923 @default.
• W2935291092 hasLocation W29352910924 @default.
• W2935291092 hasLocation W29352910925 @default.
• W2935291092 hasLocation W29352910926 @default.

• next